Clinical Trial

Prehabilitation in Breast Cancer Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized, assessor-blinded, parallel-group clinical trial evaluates the effectiveness of a home-based upper extremity-focused prehabilitation program in women undergoing breast cancer surgery. Participants will be randomized 1:1 to either prehabilitation or usual care. Primary outcomes include shoulder range of motion and upper extremity function (DASH score). Secondary outcomes include grip strength, pain, fatigue, disability, anxiety/depression, and lymphedema incidence up to 2 years postoperatively.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-15.
Trial Details
NCT Number NCT07425379
Lead Sponsor Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Conditions Breast Cancer (Early Breast Cancer), Postoperative Shoulder Dysfunction, Lymphedema Arm, Cancer Rehabilitation
Enrollment 54 participants
Start Date 2026-03-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-24